The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...

Indonesia is moving closer to localising the production of plasma-derived medicinal products (PDMPs) as SK Plasma Core Indonesia—a joint venture between South Korea’s SK Plasma and the Indonesia ...

Celestial Biologicals Limited (CBL) and GE Healthcare, the US$17 billion healthcare business of General Electric Company, announced have a collaboration to set up India’s first Good Manufacturing ...

According to the report, the global plasma fractionation market is expected to generate around $36.8 bn by 2025, at a CAGR of around 7.2% between 2019 and 2025. Worldwide Trends in Plasma ...

Report Ocean has published a new report on the “Plasma Fractionation Market” in diverse regions to produce a report with more than 250+pages. This market report is an excellent fusion of qualitative ...

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...

Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor ...

The Insight Partners published latest research study on “Plasma Fractionation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, End User, and Geography,” the ...

The global plasma fractionation market accounted for $18,222 million in 2019, and is expected to reach $23,006 million by 2027, registering a CAGR of 6.2% from 2020 to 2027. In addition, plasma ...